Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Abdominal distension? 311 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 311 reports of Abdominal distension have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.2% of all adverse event reports for RIVAROXABAN.

311
Reports of Abdominal distension with RIVAROXABAN
0.2%
of all RIVAROXABAN reports
12
Deaths
107
Hospitalizations

How Dangerous Is Abdominal distension From RIVAROXABAN?

Of the 311 reports, 12 (3.9%) resulted in death, 107 (34.4%) required hospitalization, and 20 (6.4%) were considered life-threatening.

Is Abdominal distension Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 311 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Abdominal distension?

ADALIMUMAB (3,728) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,238) LEVONORGESTREL (1,700) METHOTREXATE (1,471) TREPROSTINIL (1,437) PREDNISONE (1,429) SEMAGLUTIDE (1,424) VEDOLIZUMAB (1,411) INFLIXIMAB (1,328) POLYETHYLENE GLYCOL 3350 (1,158)

Which RIVAROXABAN Alternatives Have Lower Abdominal distension Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Abdominal distension Reports All Drugs Causing Abdominal distension RIVAROXABAN Demographics